Reported results
- Revenue from continuing operations was $23.9 million.
- Net loss was $0.5 million.
- Operating income from continuing operations was $1.0 million.
- Adjusted EBITDA (non-GAAP measure) was $5.9 million.
- Hemp-derived product revenue increased 15% sequentially to $6.4 million.
Notes
The Company is not providing an outlook for the fourth quarter of 2026 at this time due to forthcoming changes to federal law affecting hemp-derived THC products.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-04 (8-K, Item 2.02). Read the original filing on sec.gov.
